SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AB2. A total of 30 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $33,085,000 | – | 27,196,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 8,125,000 | $9,874,000 | 14.18% |
| GLAZER CAPITAL, LLC | 25,300,000 | $30,724,000 | 4.97% |
| Mohican Financial Management, LLC | 1,000,000 | $1,217,000 | 4.81% |
| Context Capital Management, LLC | 4,000,000 | $4,871,000 | 2.89% |
| Wellesley Asset Management | 34,286 | $41,722,000 | 2.20% |
| DLD Asset Management, LP | 17,500,000 | $21,350,000 | 1.55% |
| LINDEN ADVISORS LP | 41,504,000 | $50,539,000 | 1.49% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,500,000 | $6,710,000 | 1.27% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $7,912,000 | 0.64% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,720,000 | $3,305,000 | 0.54% |